Results 231 to 240 of about 8,158 (292)

Deciphering obesity: a conceptual overview and synthesis. [PDF]

Front Endocrinol (Lausanne)
Prakash R, Arora A, Khan A.
europepmc   +1 more source

Sitagliptin, Metformin and Glimepiride Fixed‐Dose Combination Compared to Co‐Administration of Metformin and High‐Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Double‐Dummy, Phase 3 Clinical Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6207-6216, July 2026.
ABSTRACT Aims This study assessed the efficacy and safety of a triple fixed‐dose combination (FDC) of sitagliptin, metformin, and glimepiride versus co‐administered metformin and glimepiride in Indian patients with uncontrolled Type 2 diabetes (T2D).
Rakesh Sahay, Ambanna Gowda, Manish Kumar Singh, A. Gopal Rao, Ramesh Duraisamy, Dinesh Gangwani, Jitendra Shukla, Vikas Agarwal, Sandesh Sahebarao Patil, Ambrish C., Satish Babu K. N., Arvind Palawat, Sandip Krishnrao Gofne, Abhay Kumar Sahoo, Pradeep Kumar Rai, Raisa Shaikh, Shruti Saha, Dipak Patil, Pravin Ghadge, Piyush Patel, Lalit Lakhwani, Suyog Mehta, Sadhna Joglekar   +22 more
wiley   +1 more source

New Perspectives in Modulating the Entero-Insular Axis in Pediatric Obesity. [PDF]

Int J Mol Sci
Dira LM, Marin LM, Popa SG, Singer CE, Cosoveanu CS, Donoiu I, Golli AL.   +6 more
europepmc   +1 more source

Higher Body Mass Index Is a Causal Risk Factor for Skin Infections: A Mendelian Randomisation Study Using UK Biobank and FinnGen

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5907-5914, July 2026.
ABSTRACT Aims Infections remain a leading cause of mortality and morbidity globally. We aimed to evaluate the potential causal role of higher BMI on common bacterial, viral and fungal infections using Mendelian randomisation (MR). Material and Methods In UK Biobank (N = 502 131, N = 230 542 with linked GP records), we tested observational associations ...
Rhian Hopkins, Ethan de Villiers, Michael N. Weedon, Beverley M. Shields, John M. Dennis, Andrew P. McGovern, Harry D. Green   +6 more
wiley   +1 more source

Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy. [PDF]

Amino Acids
Fajkić A, Lam YW, Belančić A.
europepmc   +1 more source

Hypothalamisches Incretin [PDF]

, 2019
openaire   +1 more source

Postprandial Glucagon Action in the Human Brain

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5926-5938, July 2026.
ABSTRACT Aims Elevated fasting glucagon is linked to hyperglycemia, but postprandial glucagon effects are less understood. Recent evidence suggests metabolic benefits of rising glucagon after oral glucose intake, potentially impacting brain‐mediated whole‐body metabolism.
Robert Wagner, Stephanie Kullmann, Julia Hummel, Katsiaryna Prystupa, Elena Hosenfeld, Ralf Veit, Andreas L. Birkenfeld, Hans‐Ulrich Häring, Hubert Preissl, Andreas Fritsche, Andreas Peter, Martin Heni   +11 more
wiley   +1 more source

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events. [PDF]

Arch Clin Med Case Rep
Radparvar I, Agrawal DK.
europepmc   +1 more source

Body Composition Optimization in the Era of GLP‐1‐Based Pharmacotherapy for Obesity Management

Lifestyle Medicine, Volume 7, Issue 3, July 2026.
Grant M. Tinsley, Spencer Nadolsky, Karl Nadolsky   +2 more
wiley   +1 more source

Regulation of glucose metabolism by incretins: implications for treatment of type 2 diabetes. [PDF]

Diabetol Int
Saito R, Harada N.
europepmc   +1 more source